+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gastroenteritis Drug"

Gastroenteritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Gastroenteritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 185 Pages
  • Global
From
Gastroenteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastroenteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 64 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Gastroenteritis Drug market is a subset of the pharmaceutical industry focused on the development of drugs to treat gastrointestinal illnesses. Clinical trials are an important part of the process of developing new drugs, as they provide evidence of the safety and efficacy of the drug. Clinical trials are conducted in phases, with each phase providing more detailed information about the drug's safety and efficacy. The results of the trials are then used to determine whether the drug should be approved for use by regulatory authorities. The Gastroenteritis Drug market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Sanofi. Show Less Read more